Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.

Ítems similars

• Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
  per: Nurmikko, P, et al.
  Publicat: (2002)
• Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
  per: Steuber, T, et al.
  Publicat: (2007)
• Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
  per: Steuber, T, et al.
  Publicat: (2002)
• Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
  per: Haese, A, et al.
  Publicat: (2001)
• Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
  per: Haese, A, et al.
  Publicat: (2003)